PAVmed Inc.
NASDAQ: PAVM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Lishan Aklog
- Employees
- 39
- Headquarters
- New York City, United States
- IPO year
- 2016
- Market cap
- $2.5M
- Website
- https://www.pavmed.com
Loading PAVM…
Loading profile data…Frequently asked questions about PAVM
What does PAVmed Inc. (PAVM) do?
PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and Es...
Where does PAVM trade?
PAVmed Inc. (PAVM) trades on the NASDAQ Capital Market.
What sector is PAVM in?
PAVmed Inc. (PAVM) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of PAVmed Inc.?
Lishan Aklog is the chief executive officer of PAVmed Inc. (PAVM).
Where is PAVmed Inc. headquartered?
PAVmed Inc. is headquartered in United States.
Does PAVM pay a dividend?
PAVmed Inc. (PAVM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PAVM go public?
PAVmed Inc. (PAVM) completed its initial public offering in 2016.